AMIX
Autonomix Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.66
−1.19%Price chart
Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3
Key dataNov 3, 2026
Open$1.66
From 52W high−93.13%
Volume42702.00
Market cap$3.25M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataNov 3, 2026
Open
$1.66
From 52W high
−93.13%
Volume
42702.00
Market cap
$3.25M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.0x
P/E (TTM)
—
RSI (14)
18.4
MomentumView details →
1D Return
−1.19%
YTD Return
−85.54%
SummaryUpdated Jun 1, 2026
Autonomix Medical, Inc. (NASDAQ:AMIX) is a development-stage medical device company founded in 2014 and based in The Woodlands, Texas. The company went public in January 2024 and focuses on developing innovative technologies for sensing and treating disorders related to the peripheral nervous system. As a pre-revenue company, Autonomix is currently in the research and development phase, working to advance its proprietary catheter-based sensing technology platform.
Similar companies
Latest newsMore news →
Autonomix Medical elected Walter V. Klemp, Lori Bisson, Jonathan P. Foster, David Robins, Christopher Capelli and Sandra Kalter as directors, effective October 29, 2026.16h agoAutonomix Medical strengthened patent protection for its catheter-based platform technology enabling transvascular access, treatment guidance, adaptive treatment delivery, and real-time procedural validation beyond the lumen wall.33d agoAutonomix received positive FDA pre-submission feedback supporting a 510(k) Class II pathway for U.S. clearance of its standalone sensing platform, with potential initial clearance in approximately 15 months.35d ago